144 related articles for article (PubMed ID: 38311411)
1. Ginsenosides Inhibit the Proliferation of Lung Cancer Cells and Suppress the Rate of Metastasis by Modulating EGFR/VEGF Signaling Pathways.
Yu X; Wang Q; Dai Z
J Oleo Sci; 2024; 73(2):219-230. PubMed ID: 38311411
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg5 induces NSCLC cell apoptosis and autophagy through PI3K/Akt/mTOR signaling pathway.
Zhang C; Jin Y
Hum Exp Toxicol; 2024; 43():9603271241229140. PubMed ID: 38289222
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg3 enhances the radiosensitivity of lung cancer A549 and H1299 cells via the PI3K/AKT signaling pathway.
Li J; Yang B
In Vitro Cell Dev Biol Anim; 2023 Jan; 59(1):19-30. PubMed ID: 36790693
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.
Liu Y; Fan D
Food Funct; 2018 Nov; 9(11):5513-5527. PubMed ID: 30207362
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg5 Inhibits Human Osteosarcoma Cell Proliferation and Induces Cell Apoptosis through PI3K/Akt/mTORC1-Related LC3 Autophagy Pathway.
Liu MY; Liu F; Li YJ; Yin JN; Gao YL; Wang XY; Yang C; Liu JG; Li HJ
Oxid Med Cell Longev; 2021; 2021():5040326. PubMed ID: 34257801
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg5 induces apoptosis in human esophageal cancer cells through the phosphoinositide‑3 kinase/protein kinase B signaling pathway.
Zhang D; Wang A; Feng J; Zhang Q; Liu L; Ren H
Mol Med Rep; 2019 May; 19(5):4019-4026. PubMed ID: 30942438
[TBL] [Abstract][Full Text] [Related]
10. The Preparation of Ginsenoside Rg5, Its Antitumor Activity against Breast Cancer Cells and Its Targeting of PI3K.
Liu Y; Fan D
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963684
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 enhances the anticancer effect of 5‑FU in colon cancer cells via the PI3K/AKT pathway.
Hong S; Cai W; Huang Z; Wang Y; Mi X; Huang Y; Lin Z; Chen X
Oncol Rep; 2020 Oct; 44(4):1333-1342. PubMed ID: 32945504
[TBL] [Abstract][Full Text] [Related]
12. Novel roles of ginsenoside Rg3 in apoptosis through downregulation of epidermal growth factor receptor.
Joo EJ; Chun J; Ha YW; Ko HJ; Xu MY; Kim YS
Chem Biol Interact; 2015 May; 233():25-34. PubMed ID: 25824408
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside 3β-O-Glc-DM (C3DM) suppressed glioma tumor growth by downregulating the EGFR/PI3K/AKT/mTOR signaling pathway and modulating the tumor microenvironment.
Tang M; Deng H; Zheng K; He J; Yang J; Li Y
Toxicol Appl Pharmacol; 2023 Feb; 460():116378. PubMed ID: 36641037
[TBL] [Abstract][Full Text] [Related]
14. 20(R)-ginsenoside Rg3, a rare saponin from red ginseng, ameliorates acetaminophen-induced hepatotoxicity by suppressing PI3K/AKT pathway-mediated inflammation and apoptosis.
Zhou YD; Hou JG; Liu W; Ren S; Wang YP; Zhang R; Chen C; Wang Z; Li W
Int Immunopharmacol; 2018 Jun; 59():21-30. PubMed ID: 29621733
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside-Rg5 Inhibits Retinoblastoma Proliferation and Induces Apoptosis through Suppressing BCL2 Expression.
Cui Y; Su Y; Deng L; Wang W
Chemotherapy; 2018; 63(5):293-300. PubMed ID: 30731458
[TBL] [Abstract][Full Text] [Related]
16. 20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways.
Wang JH; Nao JF; Zhang M; He P
Tumour Biol; 2014 Dec; 35(12):11985-94. PubMed ID: 25168366
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of ginsenoside Rg3 on lung injury in diabetic rats.
Wang H; Wu W; Wang G; Xu W; Zhang F; Wu B; Tian Y
J Cell Biochem; 2019 Mar; 120(3):3323-3330. PubMed ID: 30362612
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR/HIF-1α/VEGF and EMT signalling pathways.
Zeng X; Liu S; Yang H; Jia M; Liu W; Zhu W
J Pharm Pharmacol; 2023 Nov; 75(11):1405-1417. PubMed ID: 37498992
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway.
Liu T; Zuo L; Guo D; Chai X; Xu J; Cui Z; Wang Z; Hou C
Biomed Pharmacother; 2019 Dec; 120():109483. PubMed ID: 31629252
[TBL] [Abstract][Full Text] [Related]
20. [Effects of ginsenoside Rg5 on cell cycle and invasion of gastric cancer].
Zhao XY; He ZY; Zai SF
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jan; 36(1):51-54. PubMed ID: 32476373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
